We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > sartan

News List

UK Regulators Recall Batches of “Sartan” Drug for Azido Impurities americanpharmaceuticalreview
August 13, 2021
The UK Medicines and Healthcare products Agency (MHRA) is recalling 25 batches of irbesartan-containing products as a precautionary measure due to contamination with an azido impurity, which the agency says has mutagenic potential.
Blood pressure and heart medication recalled by MHRA in UK europeanpharmaceuticalreview
April 16, 2019
The MHRA have announced another sartan-containing drug product over fears that it is contaminated with the carcinogen N‑nitrosodiethylamine…
FDA declares 40 generics free of carcinogens as 'sartan' recalls continue fiercepharma
April 08, 2019
As recalls on blood pressure drugs continue to plague drugmakers, the FDA declared a slate of 40 generic pills safe to use.
MHRA recalls a further three batches of sartan-based products pharmaceutical-technology
February 14, 2019
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has announced it has recalled three more batches of irbesartan as part of its continued investigation into potential N-nitrosodiethylamine (NDEA) contamination of .....